Methvin Isaac

Person

Ontario, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted heteroaryls as inhibitors of the BCL6 BTB domain protei...
- Patent number 11,518,764
- Issue date Dec 6, 2022
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Rima Al-awar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Deuterated compounds as inhibitors of the BCL6 BTB domain protein-p...
- Patent number 11,505,539
- Issue date Nov 22, 2022
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Methvin Isaac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted carboxamides as inhibitors of WDR5 protein-protein binding
- Patent number 11,319,299
- Issue date May 3, 2022
- Propellon Therapeutics Inc.
- Rima Al-Awar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic inhibitors of the BCL6 BTB domain protein-protein interac...
- Patent number 11,242,351
- Issue date Feb 8, 2022
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Rima Al-awar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinolone compounds as inhibitors of the BCL6 BTB domain protein-pr...
- Patent number 11,192,880
- Issue date Dec 7, 2021
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Methvin Isaac
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted carboxamides as inhibitors of WDR5 protein-protein binding
- Patent number 11,174,250
- Issue date Nov 16, 2021
- Propellon Therapeutics Inc.
- Rima Al-Awar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of D-serine derivatives for the treatment of anxiety disorders
- Patent number 8,450,336
- Issue date May 28, 2013
- NPS Pharmaceuticals, Inc.
- Guy Higgins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxadiazole derivatives and their use as metabotropic glutamate rece...
- Patent number 8,377,940
- Issue date Feb 19, 2013
- Astrazeneca AB
- Joshua Clayton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazole derivatives and their use as metabotropic glutamate rece...
- Patent number 8,377,939
- Issue date Feb 19, 2013
- Astrazeneca AB
- Joshua Clayton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabotropic glutamate-receptor-potentiating isoindolones
- Patent number 8,153,638
- Issue date Apr 10, 2012
- Astrazeneca AB
- Bradford Van Wagenen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoindolone compounds and their use as metabotropic glutamate recep...
- Patent number 7,968,570
- Issue date Jun 28, 2011
- Astrazeneca AB
- Joshua Clayton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutically active compounds containing tetrazolyl and triazol...
- Patent number 7,960,422
- Issue date Jun 14, 2011
- Astrazeneca AB
- Erwan Arzel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazines and piperidines as Mglur5 potentiators
- Patent number 7,935,703
- Issue date May 3, 2011
- Astrazeneca AB
- Abdelmalik Slassi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted isoindolones and their use as metabotropic glutamate re...
- Patent number 7,868,008
- Issue date Jan 11, 2011
- Astrazeneca AB
- Bradford Van Wagenen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxazolidinone compounds and their use as metabotropic glutamate rec...
- Patent number 7,816,354
- Issue date Oct 19, 2010
- Astrazeneca AB
- Abdelmalik Slassi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabotropic glutamate-receptor-potentiating isoindolones
- Patent number 7,807,706
- Issue date Oct 5, 2010
- Astrazeneca AB
- Bradford Van Wagenen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabotropic glutamate receptor oxadiazole ligands and their use as...
- Patent number 7,799,792
- Issue date Sep 21, 2010
- Astrazeneca AB
- Joshua Clayton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-oxazolidinone compounds and their use as metabotropic glutama...
- Patent number 7,790,717
- Issue date Sep 7, 2010
- Astrazeneca AB
- Ian Egle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
mGluR5 modulators
- Patent number 7,772,235
- Issue date Aug 10, 2010
- Astrazeneca AB
- Methvin Isaac
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole compounds and their use as metabotropic glutamate recepto...
- Patent number 7,691,892
- Issue date Apr 6, 2010
- Astrazeneca AB
- Martin Johansson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MGluR5 modulators I
- Patent number 7,678,796
- Issue date Mar 16, 2010
- Astrazeneca AB
- Andreas Wallberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Additional heteropolycyclic compounds and their use as metabotropic...
- Patent number 7,585,881
- Issue date Sep 8, 2009
- Astrazeneca AB
- Louise Edwards
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds and their use as metabotropic glutamat...
- Patent number 7,576,077
- Issue date Aug 18, 2009
- Astrazeneca AB
- David Wensbo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-oxazolidinone compounds and their use as metabotropic glutama...
- Patent number 7,485,722
- Issue date Feb 3, 2009
- Astrazeneca AB
- Ian Egle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of neurological, psychiatric or pain di...
- Patent number 7,476,684
- Issue date Jan 13, 2009
- Astrazeneca AB
- Alexander Minidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 7,456,200
- Issue date Nov 25, 2008
- Astrazeneca AB
- Jalaj Arora
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteropolycyclic compounds and their use as metabotropic glutamate...
- Patent number 7,112,595
- Issue date Sep 26, 2006
- NPS Pharmaceuticals, Inc.
- Bradford Van Wagenen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 7,074,809
- Issue date Jul 11, 2006
- AstraZeneca AB
- Jalaj Arora
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds having 5-HT6 receptor antagonist activity
- Patent number 6,897,215
- Issue date May 24, 2005
- NPS Allelix Corp.
- Tao Xin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds for the treatment of migraine
- Patent number 6,716,837
- Issue date Apr 6, 2004
- NPS Allelix Biopharmaceuticals, Inc.
- Louise Edwards
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF TH...
- Publication number 20240425479
- Publication date Dec 26, 2024
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Ahn Chau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEM...
- Publication number 20240343704
- Publication date Oct 17, 2024
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Anh Chau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAE...
- Publication number 20240317723
- Publication date Sep 26, 2024
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Rima Al-Awar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERGOLINE-DERIVED AGONISTS OF THE 5-HT2A RECEPTOR
- Publication number 20240279226
- Publication date Aug 22, 2024
- Diamond Therapeutics Inc.
- Methvin ISAAC
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-HT2A AND/OR 5-HT2C RECEPTOR AGONISTS
- Publication number 20240182480
- Publication date Jun 6, 2024
- Diamond Therapeutics Inc.
- Methvin ISAAC
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINAS...
- Publication number 20240092763
- Publication date Mar 21, 2024
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Rima Al-Awar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THIENYL AND CYCLOALKYL AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF N...
- Publication number 20240025887
- Publication date Jan 25, 2024
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Rima Al-Awar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED CARBOXAMIDES AS INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING
- Publication number 20230219926
- Publication date Jul 13, 2023
- Propellon Therapeutics Inc.
- Rima AL-AWAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERAC...
- Publication number 20210053978
- Publication date Feb 25, 2021
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Rima Al-awar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING
- Publication number 20200385371
- Publication date Dec 10, 2020
- PROPELLON THERAPEUTICS INC.
- Rima Al-Awar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND U...
- Publication number 20200331921
- Publication date Oct 22, 2020
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Rima Al-awar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL QUINOLONE COMPOUNDS AS INHIBITORS OF THE BCL6 BTB DOMAIN PROT...
- Publication number 20200325119
- Publication date Oct 15, 2020
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Methvin Isaac
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL DEUTERATED COMPOUNDS AS INHIBITORS OF THE BCL6 BTB DOMAIN PRO...
- Publication number 20200308147
- Publication date Oct 1, 2020
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Methvin Isaac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING
- Publication number 20190119264
- Publication date Apr 25, 2019
- PROPELLON THERAPEUTICS INC.
- Rima Al-Awar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING
- Publication number 20190112290
- Publication date Apr 18, 2019
- PROPELLON THERAPEUTICS INC.
- Rima Al-Awar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS
- Publication number 20140018549
- Publication date Jan 16, 2014
- NPS Pharmaceuticals, Inc.
- Guy Higgins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted Isoindolones and Their Use as Metabotropic Glutamate Re...
- Publication number 20110166155
- Publication date Jul 7, 2011
- Bradford Van Wagenen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor P...
- Publication number 20110053953
- Publication date Mar 3, 2011
- Abdelmalik Slassi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Metabotropic Glutamate-Receptor-Potentiating Isoindolones
- Publication number 20100317674
- Publication date Dec 16, 2010
- Bradford Van Wagenen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as...
- Publication number 20100280082
- Publication date Nov 4, 2010
- AstraZeneca AB
- Joshua Clayton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Rece...
- Publication number 20100267740
- Publication date Oct 21, 2010
- AstraZeneca AB
- Joshua Clayton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperazine and Piperidine MGLUR5 Potentiators
- Publication number 20100144710
- Publication date Jun 10, 2010
- AstraZeneca AB
- Jalaj Arora
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS
- Publication number 20100016403
- Publication date Jan 21, 2010
- Guy Higgins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINES AS 5-HT2C LIGANDS
- Publication number 20090312306
- Publication date Dec 17, 2009
- Guangri Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoindolone compounds and their use as metabotropic glutamate recep...
- Publication number 20090275578
- Publication date Nov 5, 2009
- AstraZeneca AB
- Joshua Clayton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glut...
- Publication number 20090192169
- Publication date Jul 30, 2009
- Ian Egle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Metabotropic Glutamate Receptor-Potentiating Isoindolones
- Publication number 20090149505
- Publication date Jun 11, 2009
- AstraZeneca AB
- James R. Empfield
- C07 - ORGANIC CHEMISTRY
Information Patent Application
New compounds 067
- Publication number 20090131454
- Publication date May 21, 2009
- AstraZeneca AB
- Erwan Arzel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIRO-OXAZOLIDINONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMA...
- Publication number 20090124578
- Publication date May 14, 2009
- AstraZeneca AB
- Ian EGLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINO 1,2,4-TRIAZOLE DERIVATIVES AS MODULATORS OF MGLUR5
- Publication number 20090111821
- Publication date Apr 30, 2009
- AstraZeneca AB
- Methvin ISAAC
- C07 - ORGANIC CHEMISTRY

Methvin Isaac

Person

Patents Grantslast 30 patents

Substituted heteroaryls as inhibitors of the BCL6 BTB domain protei...

Deuterated compounds as inhibitors of the BCL6 BTB domain protein-p...

Substituted carboxamides as inhibitors of WDR5 protein-protein binding

Tricyclic inhibitors of the BCL6 BTB domain protein-protein interac...

Quinolone compounds as inhibitors of the BCL6 BTB domain protein-pr...

Substituted carboxamides as inhibitors of WDR5 protein-protein binding

Use of D-serine derivatives for the treatment of anxiety disorders

Oxadiazole derivatives and their use as metabotropic glutamate rece...

Oxadiazole derivatives and their use as metabotropic glutamate rece...

Metabotropic glutamate-receptor-potentiating isoindolones

Isoindolone compounds and their use as metabotropic glutamate recep...

Pharmaceutically active compounds containing tetrazolyl and triazol...

Piperazines and piperidines as Mglur5 potentiators

Substituted isoindolones and their use as metabotropic glutamate re...

Oxazolidinone compounds and their use as metabotropic glutamate rec...

Metabotropic glutamate-receptor-potentiating isoindolones

Metabotropic glutamate receptor oxadiazole ligands and their use as...

Spiro-oxazolidinone compounds and their use as metabotropic glutama...

mGluR5 modulators

Tetrazole compounds and their use as metabotropic glutamate recepto...

MGluR5 modulators I

Additional heteropolycyclic compounds and their use as metabotropic...

Fused heterocyclic compounds and their use as metabotropic glutamat...

Spiro-oxazolidinone compounds and their use as metabotropic glutama...

Compounds for the treatment of neurological, psychiatric or pain di...

Compounds

Heteropolycyclic compounds and their use as metabotropic glutamate...

Compounds

Compounds having 5-HT6 receptor antagonist activity

Heterocyclic compounds for the treatment of migraine

Patents Applicationslast 30 patents

HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF TH...

HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEM...

SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAE...

ERGOLINE-DERIVED AGONISTS OF THE 5-HT2A RECEPTOR

5-HT2A AND/OR 5-HT2C RECEPTOR AGONISTS

ISOINDOLINONE AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINAS...

THIENYL AND CYCLOALKYL AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF N...

SUBSTITUTED CARBOXAMIDES AS INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING

TRICYCLIC INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERAC...

INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING

INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND U...

NOVEL QUINOLONE COMPOUNDS AS INHIBITORS OF THE BCL6 BTB DOMAIN PROT...

NOVEL DEUTERATED COMPOUNDS AS INHIBITORS OF THE BCL6 BTB DOMAIN PRO...

INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING

INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING

USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS

Substituted Isoindolones and Their Use as Metabotropic Glutamate Re...

AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor P...

Metabotropic Glutamate-Receptor-Potentiating Isoindolones

Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as...

Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Rece...

Piperazine and Piperidine MGLUR5 Potentiators

USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS

TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINES AS 5-HT2C LIGANDS

Isoindolone compounds and their use as metabotropic glutamate recep...

Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glut...

Metabotropic Glutamate Receptor-Potentiating Isoindolones

New compounds 067

SPIRO-OXAZOLIDINONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMA...

AMINO 1,2,4-TRIAZOLE DERIVATIVES AS MODULATORS OF MGLUR5